Advarra Unveils New Website and United Brand
Published: May 01, 2018
Advarra’s website and brand, Altogether Better, reflects a united organization with a strong, integrated approach and a clear focus on partnership and collaboration with customers. Advarra has combined and fully harmonized its research compliance capabilities to leverage its strengths while delivering a seamless solution focused on exceptional client service, innovative technology and unmatched regulatory expertise. Advarra Consulting further supports research compliance services with global GxP, quality assurance and human research protection (HRP) consulting services.
By integrating processes across its organization, Advarra provides clients with the efficiencies of a large-scale operation while remaining committed to high-quality reviews and customer service excellence.
“Our goal is to help our clients achieve compliance without complication,” said Pat Donnelly, Advarra Chief Executive Officer. “We believe integrating best practices across the company makes Advarra altogether better and lets us offer altogether better solutions for clients. We simplify submission, tracking and review processes with innovative technologies and help clients perform research to the highest ethical standards.”
The experts at Advarra are Advancing Better Research by addressing the increasingly complex needs associated with research. They are focused on increasing the quality and efficiency of IRB, IBC and compliance consulting services with technology like the Advarra Center for IRB Intelligence (CIRBI) Platform and services including the Central Oncology Review and Central Neurology Review. New submissions and other inquiries can be submitted through advarra.com. A growing library of resources and detailed information on Advarra’s policies and processes are available by logging in to the Advarra CIRBI Platform.
For more information, visit advarra.com, or stop by Booth #1300 at the Drug Information Association (DIA) Annual Meeting, June 24–28, in Boston.
Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research review are met, while putting participants first and meeting complex human research protection oversight requirements. Advarra supports all phases of research across multiple therapeutic areas. For more information, visit advarra.com.
SCORR Marketing for Advarra
Lea Studer, 308-237-5567